WO2023173181 - STRAIN AND A BIFIDOBACTERIAL PREPARATION HAVING HYPOLIPIDEMIC, ANTI-INFLAMMATORY IMMUNOMODULATING AND INSULIN RESISTANCE DECREASING EFFECTS
National phase entry:
Publication Number
WO/2023/173181
Publication Date
21.09.2023
International Application No.
PCT/BG2023/000009
International Filing Date
16.03.2023
Title **
[English]
STRAIN AND A BIFIDOBACTERIAL PREPARATION HAVING HYPOLIPIDEMIC, ANTI-INFLAMMATORY IMMUNOMODULATING AND INSULIN RESISTANCE DECREASING EFFECTS
[French]
ET UNE PRÉPARATION BIFIDOBACTÉRIENNE PRÉSENTANT DES EFFETS HYPOLIPIDÉMIQUES, ANTI-INFLAMMATOIRES, IMMUNOMODULATEURS ET DIMINUANT LA RÉSISTANCE À L'INSULINE
Applicants **
LB BULGARICUM EAD
86 Tintyava Street
1113 Sofia, BG
Inventors
DIMITROV, Zhechko Panayotov
10 Mitropolit Panaret Street, ap. 6
Sofia 1505, BG
GOTOVA, Irina Marinova
19 Velcho Atanasov Street, ap. 53
Sofia 1505, BG
MICHAYLOVA, Michaela Lyubomirova
17 Galileo Galilei Street, block 251, ap. 19
ZK Geo Milev
Sofia 1113, BG
PASHOVA-BALTOVA, Kalinka Nikolova
ZK Krasna Polyana 2, block 36, ap. 23
Sofia 1330, BG
URSHEV, Zoltan Lubomirov
ZK Bukston, block 31A, ap.25
Sofia 1618, BG
Priority Data
113505
18.03.2022
BG
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 953 | |
| EPO | Filing, Examination | 4588 | |
| Japan | Filing | 590 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 2710 |
Total: 9415 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
3/15 NBIMCC 9085 and the bifidobacterial preparation for the prevention and therapy of atherosclerosis, cardiovascular and inflammatory diseases and to reduce the diabetes risk.[French]
3/15 NBIMCC 9085 et de la préparation bifidobactérienne pour la prévention et la thérapie de l'athérosclérose, des maladies cardiovasculaires et inflammatoires et pour réduire le risque de diabète.